跳至主要内容
临床试验/NL-OMON52886
NL-OMON52886招募中不适用

Intensive molecular and electropathological characterization of patientS undergOing atriaL fibrillATion ablatION: a multicenter prospective cohort study - ISOLATION: a multicenter prospective cohort study

Medisch Universitair Ziekenhuis Maastricht0 个研究点目标入组 650 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
650

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • In order to be eligible to participate in this registry, a subject must meet
  • all of the following criteria:
  • 18 years of age or older;
  • Documented atrial fibrillation;
  • Scheduled for AF ablation or redo AF ablation;
  • Able and willing to provide written informed consent.

排除标准

  • A potential subject who meets any of the following criteria will be excluded
  • from participation in this registry:
  • Serious patient condition before ablation;
  • Emergency procedures.
  • A subject who meets any of the following criteria will be excluded from the
  • subset in whom additional consent for transesophageal ECG (TE-ECG) is asked:
  • Known esophageal disease;
  • Previous surgery on esophagus, throat or stomach;
  • Recent (<4 weeks) myocardial infarction;
  • Unwilling to provide additional informed consent.
  • Epicardial mapping is only performed in the subset of patients undergoing
  • hybrid ablation or surgical ablation. A subject who meets any of the following
  • criteria will be excluded for this additional procedure:
  • COPD Gold II, III, or IV;
  • Heart failure, currently in NYHA class III or IV;
  • Any other pulmonary, cardiac, or other condition that may compromise a safe
  • conduct of epicardial mapping in the opinion of the treating physician or
  • investigator, taking the prolonged duration of single lung ventilation into

研究者

发起方
Medisch Universitair Ziekenhuis Maastricht

相似试验